SDR16C6P

Across TCGA pan-cancer cohorts, SDR16C6P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SDR16C6P data layer compared with 18 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher SDR16C6P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SDR16C6P expression acts as an unfavorable survival marker.

ESCA and UCEC are the cancer types where SDR16C6P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.228	0.706	<.001	24	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SDR16C6P–ESCA (OS)

Open the ESCA breakdown →